Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2, indicating a minor system update. No study data or visible page content is changed.SummaryDifference0.1%

- Check13 days agoChange DetectedEntries for Sponsor Decision and Terminated were added on 2026-02-25, and Study Design, Study Status, and Recruitment Status were updated on 2026-02-23. The recruitment option 'Enrolling by invitation' was removed on 2026-01-20.SummaryDifference0.6%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 entry and removed the funding-status notice and Revision: v3.4.1 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedAdded a government funding lapse notice and Revision: v3.4.1; removed Revision: v3.4.0.SummaryDifference0.6%

- Check48 days agoChange DetectedThe page adds a Show glossary option and clarifies color-coding for additions and deletions. The revision label was updated from v3.3.4 to v3.4.0, and the 'No FEAR Act data' text was removed.SummaryDifference0.8%

- Check55 days agoChange DetectedNew entry on 2026-01-20 adds a Study Status update. The 2025-01-17 record is removed, updating the version history.SummaryDifference0.3%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.